SEC Form 4 · accession 0001209191-18-002805
Travere Therapeutics, Inc. · TVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth E Reed
Officer — SVP, GC & Corporate Secretary
Period of report
Jan 5, 2018
Accepted (ET)
Jan 8, 2018 · 7:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438533
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 5, 2018 | S | 942 | $24.04 | D | 9,058 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were sold pursuant to a sell to cover election previously made, and confirmed by the Reporting Person during an open trading window, to cover the tax obligation that occurred upon the vesting of an RSU.